ADPT vs CVS · rev $179.0M vs P/E 16, rev $402.07B
Adaptive Biotechnologies Corp (ADPT) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported ADPT revenue for 2024-12-31 was $179.0M. Net income was -$159.6M. Revenue was up 5.1% from 2023-12-31 to 2024-12-31. ADPT currently screens at market cap $2.69B.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
ADPT currently screens at market cap $2.69B. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the ADPT and CVS stock pages for the full models.
Not investment advice.